Journey Medical Corp
DERM· Nasdaq
Released Aug 12, 2024, after the close
10-Q filed Aug 13, 2024, 44 days after period end · 0001410578-24-001326
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $14.86M | $16.96M | $18.24M | $15.29M |
| Net Income | -$3.36M | -$8.36M | -$7.53M | -$11.87M |
| EPS Diluted |
Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR
| -$0.17 |
| -$0.46 |
| -$0.43 |
| -$1.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.